𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension

✍ Scribed by Armin Sablotzki; Elke Czeslick; Susann Schubert; Ivar Friedrich; Jörg Mühling; Marius G. Dehne; Stefan Grond; Thomas Hentschel

Publisher
Springer-Verlag
Year
2002
Tongue
French
Weight
81 KB
Volume
49
Category
Article
ISSN
1496-8975

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term iloprost infusion therapy for
Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases
✍ Jose De La Mata; Miguel A. Gomez-Sanchez; Mercedes Aranzana; Juan J. Gomez-Reino 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Objective. To determine the effects of short-term, maximum-tolerated-dose and long-term, optimum-dose iloprost treatment of severe pulmonary hypertension associated with systemic sclerosis (SSc) and the primary antiphospholipid syndrome (APS). Methods. Three patients with SSc and 2 with APS who had

Improvement in pulmonary hemodynamics du
Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
✍ Michael J. Krowka; Robert P. Frantz; Michael D. McGoon; Cathy Severson; David J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Pulmonary hypertension associated with increased pulmonary vascular resistance (PVR) and occurring in the setting of portal hypertension is referred to as ''portopulmonary hypertension.'' Intravenous epoprostenol (prostacyclin) is a potent pulmonary and systemic vasodilator with antithrombotic prope

Hemodynamic effects of inhaled nitric ox
Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension
✍ De Wolf, A M ;Scott, V ;Bjerke, R ;Kang, Y ;Kramer, D ;Miro, A ;Fung, J J ;Dodso 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 71 KB

Patients with moderate and severe pulmonary hypertension have a very high mortality rate when undergoing orthotopic liver transplantation. Because nitric oxide has been successful in reducing pulmonary artery pressures in certain patients with pulmonary hypertension, the efficacy of NO inhalation (4